SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-017134
Filing Date
2024-02-27
Accepted
2024-02-27 07:10:20
Documents
2
Period of Report
2024-02-27

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0200773-6k_purple.htm 6-K 13792
2 PURPLE BIOTECH PRESENTS DATA OF ITS PHASE 1 HEAD & NECK CANCER OF NT219 IN COMBI ea0200773ex99-1_purple.htm EX-99.1 19492
  Complete submission text file 0001213900-24-017134.txt   34560
Mailing Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104
Business Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 97239333121
PURPLE BIOTECH LTD. (Filer) CIK: 0001614744 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37643 | Film No.: 24681951
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)